From: Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods study
Recommended Screening Procedure | Patients Eligible for Screeninga N | Patients Ever Receiving Recommendation N (% of total)b | Patients Observedc N (% of recommended) | Patient Adherence N (% of observed) | Average Observed Intervals (per patient) M ± SD | Average Adherence (patient) % ± SD | Total Intervals N | Intervals Met N (%) | |||
---|---|---|---|---|---|---|---|---|---|---|---|
0% adherence | > 0- < 50% adherence | 50- < 100% adherence | 100% adherence | ||||||||
Colonoscopy (total cohort) | 74 | 71 (97) | 65 (92) | 6 (9) | 2 (3) | 12 (18) | 45 (69) | 2.5 ± 2.0 | 81.5 ± 32.7 | 159 | 127 (80) |
Colon Cancer | 37 | 36 (97) | 31 (86) | 3 (10) | 0 (0) | 6 (19) | 22 (71) | 2.9 ± 2.5 | 83.2 ± 31.9 | 91 | 78 (86) |
No Colon Cancer | 37 | 35 (95) | 34 (97) | 3 (9) | 2 (6) | 6 (18) | 23 (68) | 2.0 ± 1.4 | 80.0 ± 33.8 | 68 | 49 (72) |
Genetic Counseling | 74 | 54 (73) | 46 (85) | 1 (2) | 10 (22) | 10 (22) | 25 (54) | 3.2 ± 3.0 | 73.5 ± 32.5 | 146 | 71 (49) |
Endoscopy | 74 | 51 (69) | 33 (65) | 6 (18) | 1 (3) | 7 (21) | 19 (58) | 1.9 ± 1.3 | 70.3 ± 39.5 | 63 | 41 (65) |
Urinalysis | 74 | 48 (65) | 48 (100) | 8 (17) | 8 (17) | 17 (35) | 15 (31) | 3.6 ± 2.0 | 57.7 ± 36.3 | 173 | 90 (52) |
Abdominal Ultrasound | 74 | 9 (12) | 9 (100) | 2 (22) | 1 (11) | 4 (44) | 2 (22) | 6.2 ± 3.8 | 49.4 ± 38.3 | 56 | 25 (45) |
TVUS | 31 | 12 (39) | 11 (92) | 6 (55) | 3 (27) | 1 (9) | 1 (9) | 4.0 ± 3.0 | 19.9 ± 31.3 | 48 | 10 (21) |
CA-125 | 31 | 12 (39) | 11 (92) | 1 (9) | 0 (0) | 6 (55) | 4 (36) | 3.5 ± 2.7 | 72.6 ± 31.4 | 42 | 31 (74) |
Endometrial Biopsy | 29 | 9 (31) | 9 (100) | 1 (11) | 5 (56) | 3 (33) | 0 (0) | 6.6 ± 3.4 | 36.8 ± 29.8 | 59 | 21 (36) |
Pelvic Ultrasoundd | 29 | NA (NA) | 8 (NA) | 0 (0) | 5 (63) | 2 (25) | 1 (13) | 7 ± 3.3 | 41.2 ± 34.5 | 56 | 20 (36) |